Ga-PSMA-11 PET/CT staging predicts outcomes in unfavorable intermediate- and high-risk prostate cancer
Can a new scan predict prostate cancer outcomes before surgery?
A prospective multicenter trial of 775 patients with newly diagnosed unfavorable intermediate- or high-risk prostate cancer found Ga-PSMA-11…
A new prostate scan predicts survival chances, showing men with distant spread face only 26 percent two-year survival without cancer returni…
Meta-analysis finds 47% PSA decline >50% with Ac-225/Lu-177 PSMA combination in mCRPC
Can a new two-drug radiation combo help men with advanced prostate cancer?
A meta-analysis of 323 patients with mCRPC found that Ac-225/Lu-177 PSMA radioligand combination therapy was associated with a pooled PSA de…
A new two-drug radiation combo helped 78% of men with advanced prostate cancer lower their PSA levels, with nearly half seeing a substantial…
Online rehabilitation program for sexual minority prostate cancer patients shows acceptability but minimal functional improvement
Can an online program help gay men recover sexual function after prostate cancer?
A randomized controlled trial of 401 US sexual minority men with prostate cancer tested an online biopsychobehavioral rehabilitation program…
An online rehab program for gay men after prostate cancer was easy to use but failed to improve sexual or urinary function compared to stand…